Memocept FAQ: 66 Questions, Grouped by Topic

A dietary supplement in capsules, sold for focus, memory and mental clarity. The suggested use on the label is one capsule daily, and the printed labels say a bottle holds 30 capsules. Beyond that the honest answer is complicated, because the material supplied for this product contains two completely different Supplement Facts panels under the same name.

Because there are. One label flat is teal and declares vitamin B1 6 mg, vitamin B6 8.5 mg, vitamin B12 24 mcg and a 151 mg proprietary blend containing caffeine, L-tyrosine, theacrine, theobromine, bacopa, rhodiola and huperzia. The other is purple and declares niacin 7.5 mg NE, calcium 18 mg, L-arginine 200 mg, L-arginine AKG 200 mg, L-citrulline HCL 100 mg, L-citrulline malate 100 mg and beta-alanine 40 mg. Both say Memocept.

We do not know and we are not going to guess. Nothing in the material supplied to us says which bottle ships, and the two panels share no dietary ingredient. If this matters to you — and on a formula where one version contains caffeine and the other does not, it should — ask the order desk on +1 (507) 448-8190 before you pay, and check the bottle against the panels on our ingredients page when it arrives.

They could be a reformulation, a regional variant or two products that ended up in one folder. All three happen. What we can say is what is printed: same product name, same serving size, same servings per container, same suggested-use sentence, and then different vitamins, different actives, different other-ingredients lines, different front-panel claims and different distributors in different states.

Because picking one would be inventing a fact. This desk's rule is that the label wins and that nothing gets made up. We were sent two labels, so we have transcribed two labels, annotated two labels and scored the pack as the pack actually is.

The bottle. Always. Everything on this site is read off the artwork supplied to us, and if the physical label in your hand says something different, the physical label is the document that governs. Tell us at [email protected] and we will correct the page.

On the teal label, a single line reading Proprietary Blend 151 mg with a dagger, followed by seven ingredient names with no individual amounts. The 151 mg is the total for all seven together.

Yes. The FDA's labeling guide requires the total weight of the blend on the same line as its name, and the ingredients listed underneath “in descending order of predominance by weight.” This label does both. Lawful and uninformative are not opposites.

Descending order of predominance means the first ingredient is the heaviest, the second no heavier than the first, and so on. If seven ingredients total 151 mg, the one in position n can be no more than 151 divided by n. That upper bound is the only number the label permits us to calculate, so it is the only number we print.

Caffeine from green coffee bean at most 151 mg; L-tyrosine at most 75.5 mg; theacrine at most 50.3 mg; theobromine at most 37.8 mg; bacopa monnieri extract at most 30.2 mg; rhodiola root at most 25.2 mg; huperzia serrata extract at most 21.6 mg.

No, and this is the part worth sitting with. The rule sets an order, not a floor. Every one of those seven could be present at a fraction of a milligram and the label would still be correct as printed. The ceilings are the best case, not an estimate.

The usual reasons given are protecting a formulation from copying and keeping supplier costs private. Those are real commercial interests. The effect on a buyer is that the single most useful question — how much of this am I taking — cannot be answered from the bottle.

Not published. Caffeine from green coffee bean is the first ingredient in the blend, which by the descending-order rule means it is the heaviest of the seven and could in principle be the entire 151 mg. No milligram figure appears on the label, in the brief or on the listing.

The FDA puts a 12-fluid-ounce cup of brewed coffee at 113 to 247 milligrams, and 400 mg a day as the amount “not generally associated with dangerous, negative effects” in healthy adults. So the ceiling here is roughly between half a cup and a cup and a half of coffee. The floor is zero.

That is exactly the question the label prevents you from answering. If you already drink two or three cups a day you are at or near the FDA's 400 mg figure before you take the capsule, and you cannot add an unprinted number to that total. This is our strongest practical objection to the teal label.

Caffeine is caffeine; the source describes where it was extracted from, not a different molecule. Green coffee bean extract also contains chlorogenic acids, but this label declares the ingredient as caffeine from green coffee bean, which is a caffeine declaration.

Theacrine and theobromine are third and fourth in the blend. Theacrine is a caffeine-like alkaloid and theobromine is the stimulant in cocoa. So three of the first four positions in a memory capsule are stimulant-class compounds, and none of them has a printed amount.

We do not publish an answer, because we do not have a source we would stand behind. None of the government fact sheets or professional monographs this desk uses covers it. Rather than paraphrase a supplement marketer, we are telling you the gap exists.

The same answer. It is well known as the stimulant in cocoa, but none of the sources we opened gives a supplement dose, an effect at a supplement dose or a safety figure we would print. So we print none.

Bacopa monnieri is the ingredient in this blend with the most substantial cognition literature behind it, and it sits fifth of seven. The professional monograph we read records trial dosages that “typically ranged from 300 to 450 mg/day” over durations “typically 12 weeks.” Fifth position caps the extract here at 30.2 mg, which is a tenth of the bottom of that range at best.

It helps us, and we are glad it is there. A standardisation percentage turns a ceiling on the extract into a ceiling on the active fraction: 20% of 30.2 mg is at most 6 mg of bacosides A and B. Most labels do not print a standardisation at all.

The monograph records that commonly reported adverse effects are flu-like symptoms, GI irritation, nausea, increased intestinal motility and muscle fatigue, and that a safety study reported mild GI effects such as epigastric burning, nausea, fullness and bloating that subsided without stopping treatment.

NCCIH's position is the one to read first: “There isn't enough reliable evidence to determine whether rhodiola or its components are useful for any health-related purpose.” Sixth of seven caps it at 25.2 mg here, but the dose question is downstream of the evidence question.

NCCIH records that it is possibly safe for up to 12 weeks, that side effects may include dizziness, headache, insomnia and either dry mouth or excessive saliva, and that interactions between rhodiola and losartan have been reported. Losartan is a blood-pressure drug.

This is the one row where the arithmetic lands inside the studied range, and we say so plainly. Seventh of seven caps the herb extract at 21.6 mg; at the printed 1% standardisation that is at most 216 micrograms of huperzine A, against the 0.2 to 0.4 mg/day the monograph records for Alzheimer disease.

It cuts both ways, which is why it gets its own question. An ingredient present at a studied amount is an ingredient that can act like one. The monograph records cholinergic side effects in trials — hyperactivity, nasal obstruction, nausea, vomiting, diarrhea, insomnia, anxiety, dizziness, thirst and constipation — and states that “concomitant use of huperzine A with cholinesterase inhibitors could lead to potentiation of adverse reactions.”

A class of prescription medicine used in Alzheimer's disease; donepezil, rivastigmine and galantamine are the common ones. The overlap is the point: a supplement sold for memory may be bought by people already taking a prescription for memory. The label's caution panel names no medicine at all, only “a medication” in general.

An amino acid, second in the blend, so at most 75.5 mg. The monograph we read records that manufacturers commonly recommend 500 to 1,500 mg a day, and that the cognition study it describes gave 2 grams in 400 mL of orange juice before participants inhibited unwanted actions more efficiently than on placebo. The ceiling here is about a seventh of the bottom of the retail range.

They are the best-made part of the teal label. Vitamin B1 at 6 mg, B6 at 8.5 mg and B12 at 24 mcg, and all three printed percentages are arithmetically correct against the FDA's Daily Values of 1.2 mg, 1.7 mg and 2.4 mcg. Whether you need them depends on your diet, and a supplement is not the only way to get them.

It is five times a labelling reference figure, which is a different thing from a dangerous amount. The adult Tolerable Upper Intake Level for B6 is 100 mg a day, and the severe sensory neuropathy described in the NIH fact sheet followed 1 to 6 grams a day for 12 to 40 months. At 8.5 mg a day this is not that conversation.

24 micrograms against a Daily Value of 2.4 micrograms. B12 has no Tolerable Upper Intake Level set, because no adverse effects have been associated with excess intake from food or supplements in healthy people. Large multiples are ordinary on B12 labels.

NCCIH's digest on supplements and cognitive function does review B vitamins among others. We are not going to summarise a review we would then be quoting out of context; the link is on our sources page and it is worth reading whole. What we will say is that a deficiency is a medical question for a clinician, not a shopping question.

Niacin 7.5 mg NE at 47%, calcium as calcium carbonate 18 mg at a printed 1,5%, L-arginine base 200 mg, L-arginine AKG 2:1 extract 200 mg, L-citrulline HCL 100 mg, L-citrulline malate 100 mg and beta-alanine 40 mg. Other ingredients: hypromellose vegetable capsule, vegetable stearate and silicon dioxide.

In one important respect, yes: it prints an amount for every dietary ingredient. There is no blend and nothing hidden inside a total. That is the disclosure this desk asks for on every product it reviews.

Disclosure is what lets you see that they are not. The monograph we read puts arginine daily dosage trends at 6 to 30 grams in three divided doses, against 400 mg here counting both arginine forms. The NIH records a citrulline malate protocol at 8 grams, against 100 mg here. Beta-alanine was studied at 1.6 to 6.4 grams a day, against 40 mg.

Arginine, citrulline and beta-alanine are the standard contents of a pre-workout supplement, and four of the five appear in the NIH's fact sheet on exercise and athletic performance. NCCIH's digest on supplements and cognitive function does not mention amino acids at all.

Arginine bound to alpha-ketoglutarate in a stated 2:1 ratio. None of the sources we opened converts that ratio into an arginine figure or covers the form separately, so this site does not convert it and does not claim it has evidence of its own.

We do not know. The panel lists L-citrulline HCL 100 mg and L-citrulline malate 100 mg as separate items. The NIH gives the conversion for the malate — 56.64% citrulline by weight — and gives none for the hydrochloride, so we print no combined citrulline figure.

40 mg, against a studied range of 1.6 to 6.4 grams a day over four to eight weeks. The same NIH source notes that beta-alanine causes tingling or burning at doses of at least 800 mg, so at 40 mg you will feel nothing — which is both a comfort and a measurement.

The written brief names six ingredients and beta-alanine is not among them, although it is printed on the panel at 40 mg. Nothing is being concealed: the panel governs and it declares all seven. But a buyer reading only the marketing copy has seen six of seven.

All five of them, across both panels. Four are exactly right: B1 at 500%, B6 at 500%, B12 at 1000% and niacin at 47%. One is not.

The calcium. The FDA's Daily Value for calcium is 1,300 mg, and 18 divided by 1,300 is 1.4%, which to the nearest whole percent is 1%. The panel prints 1,5%. That is neither the correct value nor a whole percent.

We do not know. A comma as a decimal separator is the European convention, and this is a US label — the same panel prints 7.5 and 2:1 in US style. It is a small error about a small quantity and it changes nothing a buyer would do. We report it because a desk that recalculates percentages has to publish what the recalculation found.

Correct. The Daily Value is 16 mg NE, and 7.5 divided by 16 is 46.9%, which to the nearest whole percent is 47%.

It reads “**Percent Daily Values are based on a 2,000 calorie diet. †Daily Value not established.” The dagger half is used — the blend line carries one. The double-asterisk half is not: no line on that panel bears a double asterisk, and the three percentages that are printed carry no symbol at all.

Both labels say the same thing: as a dietary supplement, take one (1) capsule daily. Neither gives a time of day, a water volume or a with-or-without-food instruction.

Neither label says. If the bottle you receive is the teal one, the first ingredient in its blend is caffeine and the third and fourth are theacrine and theobromine, so a morning dose is the obvious reading — but we are reasoning from the ingredient order, not quoting an instruction, because there is no instruction to quote.

Not specified on either label. If a capsule containing an undeclared amount of caffeine unsettles your stomach, food is the ordinary remedy, and your own experience is better evidence here than anything we could publish.

Thirty days, taking the printed label at its word: 30 capsules, one a day. Note that every bottle photograph in this pack shows 60 capsules, and that no label matching a 60-count bottle was supplied to us. All supply arithmetic on this site uses 30.

Take the next one at the usual time. Do not double up — both labels say not to exceed the recommended dose, and on a formula with an undeclared caffeine content that instruction has teeth.

Both labels say to store the product in a cool, dry place below 30°C (86°F), and to keep it out of reach of children. Not the bathroom shelf and not a sunny windowsill.

Not on the artwork supplied to us. The brief says the lot and best-before appear on the base of the bottle when the bottle shows them. The lot reference given is MEM-26/ME-2440.

Nobody has published a trial on either of these formulas, so there is no answer from evidence. The one comparable duration we can point at is the bacopa literature, where trials typically ran twelve weeks — at dosages roughly ten times the ceiling here.

We cannot tell you that, and neither can the teal label, because it does not say how much of anything is in it. What we can do is list the specific cautions our sources record and let you take them to a clinician: the huperzine and cholinesterase-inhibitor interaction, the rhodiola and losartan interaction, and the caffeine question.

For huperzine A the monograph lists hyperactivity, nasal obstruction, nausea, vomiting, diarrhea, insomnia, anxiety, dizziness, thirst and constipation. For bacopa, flu-like symptoms, GI irritation, nausea, increased intestinal motility and muscle fatigue. For rhodiola, dizziness, headache, insomnia and dry mouth or excess saliva. None of those is on this product's label.

Ask the person who prescribes it, and take both panels with you. The two specific interactions in our sources are huperzine A with cholinesterase inhibitors and rhodiola with losartan, and on the other label arginine carries a caution about nitrates. Both labels' caution panels say to consult a physician if you are taking a medication.

It matters if you receive the purple bottle. The arginine monograph we read states that “L-arginine is not recommended following acute myocardial infarction”, after a trial was stopped early when 8.6% of the arginine group died against none in the control group. That is a reason to establish which bottle you are being sent before you order.

Then both labels have something for you to raise with a clinician. On the teal one, NCCIH records reported interactions between rhodiola and losartan. On the purple one, the arginine monograph warns about concomitant use with nitrates and describes effects on other drugs as unpredictable.

Both labels say no, in their own caution panels, and the brief says adults 18 and over. NCCIH also notes that little is known about whether rhodiola is safe during pregnancy or breastfeeding.

No. Both labels say so explicitly.

Not published, and not answerable from the label. If you receive the teal bottle its blend is led by caffeine with theacrine and theobromine behind it, and none of the three has a printed amount. It is worth noting that one of the bonuses supplied with this product is an e-book about sleep.

Green coffee beans, bacopa, rhodiola root and huperzia serrata are all on the teal panel, so those four are accurate for that bottle. They are on none of the purple panel's seven lines. The written brief, meanwhile, describes the purple panel. The pictures and the words are about different formulas.

We do not know, and we are not going to caption it with an ingredient name to make the page tidier. It is an uncaptioned stone fruit photographed with water droplets. Nothing resembling it appears on either panel.

It does, on every render in the pack, including all the multi-bottle sets. Both printed label flats say 30 Capsules and both panels say Servings Per Container: 30. We have used 30 for every supply calculation on this site, because the label governs.

A wordmark printed on every bottle render, beside a double-ring logo, next to the line Cognitive Support Formula®. It appears on neither printed label flat and in none of the written material supplied to us. We do not know what it is.

The printed flat carries no symbol on that line; the renders add one. A registered-trademark symbol asserts a registration, and no registration number appears anywhere in the material we were given. We record the difference and draw no conclusion.

There are twelve, and each one gets its own entry on our quality and safety page. The short version: the money-back roundel has a policy behind it, the vegetarian mark is supported by the printed other-ingredients lines, two of the three origin marks agree with the label, and the doctor-formulated mark names no doctor.

Two of them read Foreign and Domestic Ingredients, which matches the purple label's own Manufactured in the USA with globally sourced ingredients — the qualified construction the FTC describes. The third reads Manufacture in USA, unqualified, which the FTC reserves for products that are “all or virtually all” made in the United States. The teal label prints no origin statement at all.

Nobody is named. No qualification, no institution, no registration number. A photograph of a smiling man appears in the pack without a caption identifying him as a clinician, and we have not presented him as one.

There is, and both of this product's labels carry a boxed disclaimer saying it is not intended to diagnose, treat, cure or prevent any disease. 21 CFR 101.93 lists statements in material accompanying a product among the ways a disease claim may be made. We raise the point; we are not lawyers and this is not a legal opinion.

No dietary supplement is. The FDA states that it “does not have the authority to approve dietary supplements before they are marketed.” The badge on the listing says FDA registered facility, which means a factory filed a registration — an administrative step, not an assessment of this product.

Good Manufacturing Practice is a process standard about how a facility is run. No certifying body is named and no certificate was supplied to us. A GMP-compliant factory can competently bottle a blend whose contents are undeclared.

No laboratory is named and no report was supplied. The brief gives a CoA reference, MEM-2440-26-ME, and states in its own words that it is a draft label rather than lab proof. This site publishes no lab document it has not been sent.

Because the review block supplied to us is marked, in its own source document, as layout copy only. Publishing star scores and order counts that a document describes as placeholder text would be inventing evidence, so we publish none of it.

No manufacturer is named on either label. The teal label says Distributed by: LOJA EXPERIENCE LTDA, Aurora, CO 80011. The purple label says DISTRIBUTED BY: GEX CORPORATION LLP, PO BOX 12730, OGDEN, UT 84404. Two companies, two states, and a third name — OVICIA — on the bottle renders.

21 CFR 101.5 requires the name and place of business, and permits the street address to be left off “if it is shown in a current city directory or telephone directory.” One label gives a city, state and ZIP; the other gives a PO Box. We have no way to check the directory condition, so we state the rule and stop there.

No. The email address on the other label, and in the brief, is [email protected]. The purple label has set it as a domain name and spelled customer as costumer. Use +1 (507) 448-8190 or [email protected] for orders.

There is only one in this pack: +1 (507) 448-8190. It is printed on the purple label and it is the number the brief gives for orders, tracking, changes and refunds. The teal label prints no telephone number at all.

Memoceptmind, the U.S. stocking partner for Memocept. We are a stocking partner, not the manufacturer and not a clinic. Product facts on this site follow the label and the sales page.

We earn on orders placed through this site. That is precisely why the honest version of this page matters: the sentence telling you that two different formulas arrived under one product name costs us sales rather than earning them, and it is on the home page, the ingredients page and this one.

Three things. Which of the two labels ships. Whether the bottle holds 30 capsules or 60. And how much caffeine is in a capsule. If you get an answer to the third one, we would like to hear it at [email protected], and we will publish it with the date.

Not published to us. Pack prices are the ones printed on the info page at checkout. This site prints no figure it has not seen.

We cannot calculate it, because no price was published. At one capsule a day a printed bottle is thirty days, so the arithmetic is simple once you have the figure in front of you at checkout.

One bottle, if you buy at all. Thirty capsules is thirty days on the printed label and the guarantee is sixty, so a single bottle finishes with the window still half open. We would not commit six months to a product whose asset pack contains two different formulas.

On memoceptmind.com, so that the refund window on this desk applies to your order. Our order page is the only buy link on this site.

Not published. Orders ship from the United States unless the sales page says otherwise, and a tracking number arrives in the order email.

60 days from purchase, per the brief, unless the sales page prints a longer window. It is a purchase policy, not a medical promise. Claim it by calling +1 (507) 448-8190 with your order ID.

Three to five business days after the desk credits it, then a further five to ten days for the card to show it. Return shipping is at your cost and should be sent with tracking.

Call +1 (507) 448-8190 with the order ID first. Put your full name, the email address on the order and the order ID on a sheet inside the parcel, and send it with tracking at your own cost to 300 Park Avenue, Floor 17, New York, NY 10022.

Use [email protected] for orders and refunds. The website email, [email protected], cannot see orders — it is for pages, typos, privacy and press.

Because the pieces are better than the whole. Four of five printed percentages are exact, the purple panel is fully disclosed, both caution panels are properly worded and huperzine A's ceiling lands inside its studied range. But two panels, two distributors, three trade names and two capsule counts do not describe one product, and we could not tell a reader what is in the bottle.

Yes, three things. The three B-vitamin percentages on the teal panel are exact. The purple panel prints an amount for every dietary ingredient, which most of its competitors do not. And both labels print the two standardisation percentages and the storage temperature that many labels leave off. None of that is nothing.